Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus

R Bou, A Adán, F Borrás, B Bravo, I Calvo… - Rheumatology …, 2015 - Springer
Uveitis associated with juvenile idiopathic arthritis (JIA) typically involves the anterior
chamber segment, follows an indolent chronic course, and presents a high rate of uveitic …

Evidence for tocilizumab as a treatment option in refractory uveitis associated with juvenile idiopathic arthritis

…, K Kotaniemi, JH de Boer, R Bou… - The Journal of …, 2016 - jrheum.org
Objective. To report on experience using the anti-interleukin 6 receptor antibody tocilizumab
(TCZ) to treat severe and therapy-refractory uveitis associated with juvenile idiopathic …

Diagnosis and classification of Kawasaki disease

J Sánchez-Manubens, R Bou, J Anton - Journal of autoimmunity, 2014 - Elsevier
Kawasaki disease is an acute systemic vasculitis of unknown etiology. Diagnosis is based
on clinical criteria that include fever, exanthema, conjunctivitis, changes in the extremities, …

Severity of GNAO1‐Related Disorder Correlates with Changes in G‐Protein Function

…, J Armstrong, R Blanco‐Lago, R Bou… - Annals of …, 2023 - Wiley Online Library
Objective GNAO1‐related disorders (OMIM #615473 and #617493), caused by variants in
the GNAO1 gene, are characterized by developmental delay or intellectual disability, …

[HTML][HTML] Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis

…, M Díaz-Llopis, D Salom, R Bou… - Mediators of …, 2013 - hindawi.com
Purpose. To assess the efficacy and safety of adalimumab in patients with juvenile idiopathic
arthritis (JIA) and associated refractory uveitis. Design. Multicenter, prospective case series. …

Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population

J Sánchez-Manubens, J Antón, R Bou… - Rheumatology …, 2016 - Springer
Kawasaki disease is an acute self-limited systemic vasculitis common in childhood. Intravenous
immunoglobulin (IVIG) is an effective treatment, and it reduces the incidence of cardiac …

[PDF][PDF] Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort

…, B Sevilla, F Cabades, R Bou… - Clin Exp …, 2015 - clinexprheumatol.org
Objective. Cryopyrin-associated periodic syndromes (CAPS) are dominantly-inherited
autoinflammatory diseases. The uncontrolled IL-1β overproduction observed in these patients is …

Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-α therapy: a clinical practice observational study of patients who …

E Iglesias, V Torrente-Segarra, R Bou, S Ricart… - Rheumatology …, 2014 - Springer
TNF-alpha-blocking agents (anti-TNF) used in juvenile idiopathic arthritis (JIA) are well
established; however, time to withdraw is unclear. Neither prolonged nor tapering treatment …

Treatment of uveitis associated with juvenile idiopathic arthritis

R Bou, E Iglesias, J Antón - Current rheumatology reports, 2014 - Springer
Chronic anterior uveitis affects 10–30 % of patients with juvenile idiopathic arthritis (JIA) and
is still a cause of blindness in childhood. In most patients it is asymptomatic, bilateral, and …

[HTML][HTML] Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children

R Galindo-Zavala, R Bou-Torrent… - Pediatric …, 2020 - Springer
Background Osteoporosis incidence in children is increasing due to the increased survival
rate of patients suffering from chronic diseases and the increased use of drugs that can …